NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its revised May 2025 timeline. OneRF system targets trigeminal neuralgia, a condition impacting ~100K in the U.S., using ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...

LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with transvaginal radiofrequency (RF) nerve ablation, a small prospective ...

has filed its 510(k) submission to the FDA for trigeminal nerve ablation earlier than previous guidance.

The submission and potential FDA clearance may lead to revenue generation from the trigeminal nerve ablation market, enhancing the company's financial outlook for late 2025. This press release ...

The submission was completed earlier than anticipated, noted the company. The OneRF Trigeminal Nerve Ablation System features a minimally invasive, temperature-controlled RF procedure that uses a ...

A group of Texas-based researchers has developed an effective way to treat post-traumatic stress disorder (PTSD) that involves zapping the vagus nerve around the neck, using a device the size of a ...

Dave Rosa, President and CEO of NeuroOne, stated: “Our OneRF ® ablation technology platform has already achieved successful commercialization and patient outcomes in lesioning nerve tissue for ...

It’s not as “perfect as they are selling it,” but it does avoid the more catastrophic complications of thermal ablation, says ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...